Can you provide the last earnings date for INVO BIOSCIENCE INC?
INVO BIOSCIENCE INC (INVO) last reported earnings on 8/12/2024.
NASDAQ:INVO • US44984F4019
Past quarterly earnings results for INVO BIOSCIENCE INC (INVO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2024 | - | - | 1.837M | - | 473.94% | |||
| Q1 2024 | - | - | 1.576M | - | 350.37% | |||
| Q4 2023 | - | - | 1.382M | - | 393.48% | |||
| Q3 2023 | -0.70 | - | 83.33% | 980K | - | 308.33% | ||
| Q2 2023 | -3.06 | - | 33.48% | 320K | - | 113.33% | ||
| Q1 2023 | -0.20 | - | 95.45% | 350K | - | 118.75% | ||
| Q4 2022 | -4.60 | -3.88 | -18.68% | -38,233.33% | 280K | 262.14K | 6.81% | -90.82% |
| Q3 2022 | -4.20 | -2.65 | -58.37% | -1,650.00% | 240K | 510K | -52.94% | 9.09% |
| Q2 2022 | -4.60 | -4.90 | 6.05% | -2,605.88% | 150K | 338.13K | -55.64% | -28.57% |
| Q1 2022 | -4.40 | -5.10 | 13.73% | -1,660.00% | 160K | 248.88K | -35.71% | -76.47% |
| Q4 2021 | -0.01 | -0.23 | 94.77% | 98.00% | 3.05M | 213.863K | 1,326.14% | 1,425.00% |
| Q3 2021 | -0.24 | -0.20 | -17.65% | - | 220K | 332.01K | -33.74% | -35.29% |
| Q2 2021 | -0.17 | -0.19 | 12.28% | - | 210K | 417.69K | -49.72% | -16.00% |
| Q1 2021 | -0.25 | -0.18 | -40.06% | - | 680K | 604.86K | 12.42% | 161.54% |
| Q4 2020 | -0.60 | -0.22 | -173.60% | - | 200K | 449.82K | -55.54% | - |
| Q3 2020 | - | - | 340K | - | - | |||
| Q2 2020 | - | - | 250K | - | - | |||
| Q1 2020 | - | - | 260K | - | - |
Notes
INVO BIOSCIENCE INC (INVO) last reported earnings on 8/12/2024.
INVO BIOSCIENCE INC (INVO) missed EPS estimates and missed revenue estimates in the most recent quarter.